NCT00003641 2026-02-25High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III MelanomaEastern Cooperative Oncology GroupPhase 3 Active not recruiting1,150 enrolled 6 charts
NCT02323659 2022-01-13Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell LymphomasPolish Lymphoma Research GroupPhase 4 Terminated100 enrolled